Overview
What is Institute For Gene Therapies?
The Institute for Gene Therapies (IGT) is a not-for-profit organization situated in Washington D.C. Their primary mission is to promote a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies, thereby enhancing patient access. To accomplish this, IGT focuses on educating various stakeholders, including policy makers, the media, patients, and healthcare providers, about the science of gene and cell therapies. By advocating for a modernized regulatory framework, IGT seeks to foster curative innovations, guarantee patient access, and implement transparent reimbursement practices for the benefit of patients, families, and caregivers dealing with rare and complex medical conditions.
Official website here: www.gene-therapies.org
Is Institute For Gene Therapies legitimate?
Institute For Gene Therapies is a legitimate nonprofit organization registered as a 501(c)(4) entity. Institute For Gene Therapies submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.gene-therapies.org
What is the mission statement of Institute For Gene Therapies?
The Institute for Gene Therapies (IGT) is dedicated to spreading awareness and advocating for the field of gene and cell therapies. Their mission involves educating various stakeholders, including policy makers, media, patients, and healthcare providers, about the intricacies of these therapies. Additionally, IGT advocates for a modernized regulatory framework that fosters curative innovations, ensures patient access, and establishes transparent reimbursement practices. This is all aimed at benefiting patients, families, and caregivers dealing with rare and complex medical conditions.
Official website here: www.gene-therapies.org
Who is the CEO of Institute For Gene Therapies?
Michael Capaldi is the Chairman of Institute For Gene Therapies.
Official website here: www.gene-therapies.org
What is the revenue of Institute For Gene Therapies?
Institute For Gene Therapies's revenue in 2022 was $1,325,000.
Official website here: www.gene-therapies.org
Who are the executives of Institute For Gene Therapies and what are their salaries?
Here are 4 key members and their salaries:
- Compensation: $120,000
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.gene-therapies.org
Where can I find the form 990 for Institute For Gene Therapies?
Institute For Gene Therapies's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.gene-therapies.org
Learn more at the official website: www.gene-therapies.org
Mission Statement of Institute For Gene Therapies
The Institute for Gene Therapies (IGT) is committed to spreading awareness and advocating for the science of gene and cell therapies. Their mission is threefold. Firstly, IGT aims to educate policy makers, media outlets, patients, and healthcare providers about the intricacies of gene and cell therapies. Secondly, the organization advocates for a modernized regulatory framework that encourages curative innovations, promotes patient access, and establishes transparent reimbursement practices. This framework is intended to improve the lives of patients, families, and caregivers dealing with rare and complex medical conditions.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Institute For Gene Therapies (IGT) plays a vital role in advancing the field of gene and cell therapies by educating various stakeholders, including policymakers, media, patients, and healthcare providers about the science behind these innovative treatments. IGT advocates for a regulatory and reimbursement framework that supports the development of transformative therapies, aiming to foster an environment where curative innovations can thrive.
By promoting patient access to these cutting-edge treatments, IGT seeks to improve outcomes for individuals with rare and complex medical conditions. Their work emphasizes the importance of transparency in reimbursement practices, ensuring that advancements in gene therapy can reach those who need them most. Through these efforts, IGT contributes significantly to reshaping the landscape of medical research and treatment accessibility, ultimately benefiting patients, families, and caregivers.
This information is meant to be a general summary of Institute For Gene Therapies. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Gross Receipts: $1,325,000
Assets and Liabilities:
- Total Assets: $538,185
- Total Liabilities: $185,756
- Net Assets: $352,429
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2019
Phone
(985) 707-9104Principal Officer
Michael Capaldi
Main Address
909 E STREET NW 2ND FL, WASHINGTON, DC, 20004
Website
www.gene-therapies.orgNTEE Category
Code: H92 - Medical research
If you are a representative of Institute For Gene Therapies and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.